CA
NZ
UK
AU
IND
US
Agenus Inc (NASDAQ:AGEN) stock surged 21.28% to $3.99 on March 17, 2026, driven by investor enthusiasm following the company's announcement of a transformative strategic collaboration with Zydus Lifesciences to advance its flagship botensilimab and balstilimab (BOT+BAL) immunotherapy program. The $141 million partnership, including $75 …
The intersection of artificial intelligence and drug discovery represents one of the most promising frontiers in biotechnology. Computational approaches to protein design and drug candidate optimization have demonstrated potential to accelerate development timelines and improve drug properties. Absci is attempting to build a pure-play …
Advanced Biomed Inc. (NASDAQ:ADVB) stock has declined 16.21% to $4.55 following its March 2025 Nasdaq IPO, reflecting significant investor skepticism about the company's ability to commercialize its proprietary microfluidic circulating tumor cell (CTC) detection technology. The company's IPO was dramatically downsized from originally planned …
Why is WCT stock falling today? The decline appears to be driven by a combination of company-specific developments and broader macroeconomic headwinds. The sharp decline likely reflects concerns about competitive pressures in China's digital health market and questions about profitability. Regulatory uncertainty in China's …
Why is RDNT stock falling today? The decline appears to be driven by a combination of company-specific developments and broader macroeconomic headwinds. Healthcare reimbursement pressures affecting imaging center profitability. Concerns about utilization rates and pricing power. For investors tracking this name, understanding the catalysts …
Shares of Neogen Corporation (NASDAQ: NEOG) experienced a notable pullback on March 7, 2026, with the stock price dropping 9.3% to close at $9.70. The move caught the attention of both retail and institutional investors, as the company joined a broader wave of selling …
Why is LIXT stock falling today? The decline appears to be driven by a combination of company-specific developments and broader macroeconomic headwinds. Clinical trial challenges or slow enrollment. Broader biotech funding pressures and early-stage valuation declines. For investors tracking this name, understanding the catalysts …
Why is DRTS stock falling today? The decline appears to be driven by a combination of company-specific developments and broader macroeconomic headwinds. The decline may reflect concerns about clinical development progress, funding challenges, or competitive developments. Valuation or technical hurdles in advancing alpha radiation …
Why is ECOR stock falling today? The decline appears to be driven by a combination of company-specific developments and broader macroeconomic headwinds. Slow adoption of vagus nerve stimulation therapy for migraines and other conditions. Insurance coverage uncertainty affects patient access. For investors tracking this …
Vir Biotechnology (NASDAQ:VIR) announced quarterlyearningsof (USD 0.31) per share. In the same quarter last year, the company reportedearningsof (USD 0.76) per share.
Please wait processing your request...